Carsten G. Bönnemann, MD

Senior investigator, Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke/National Institutes of Health

Articles by Carsten G. Bönnemann, MD

Carsten Bönnemann, MD, on Identifying At-Risk Genotypes for DMD Gene Therapy

ByCarsten G. Bönnemann, MD

May 23rd 2022

The senior investigator from NINDS discussed findings investigating serious AEs across different trials.

Carsten G. Bönnemann, MD

Articles by Carsten G. Bönnemann, MD

Carsten Bönnemann, MD, on Identifying At-Risk Genotypes for DMD Gene Therapy

Latest Updated Articles

Trending on CGTlive®

FDA Activity Recap: October 2025 Features New Platform Technology Designation, RDEA Pilot Program Selection, and More